Amat-Fernandez, Clara https://orcid.org/0000-0001-9595-0970
Garin, Olatz https://orcid.org/0000-0001-6193-0779
Luer-Aguila, Ricardo https://orcid.org/0009-0004-7730-0658
Pardo, Yolanda https://orcid.org/0000-0003-4982-5495
Briseño, Renata https://orcid.org/0009-0003-2893-5270
Lizano-Barrantes, Catalina https://orcid.org/0000-0003-1690-631X
Rojas-Concha, Leslye https://orcid.org/0000-0002-6814-7426
S.Y. Thong, Melissa https://orcid.org/0000-0002-6987-705X
Apolone, Giovanni https://orcid.org/0000-0001-5179-104X
Brunelli, Cinzia https://orcid.org/0000-0003-3905-1289
Caraceni, Augusto https://orcid.org/0000-0002-0375-6204
Couespel, Norbert
Bos, Nanne
Groenvold, Mogens
Kaasa, Stein
Ciliberto, Gennaro https://orcid.org/0000-0003-2851-8605
Lombardo, Claudio https://orcid.org/0000-0001-7554-449X
Pietrobon, Ricardo
Pravettoni, Gabriella https://orcid.org/0000-0002-4843-4663
Sirven, Aude https://orcid.org/0009-0007-8222-0961
Vachon, Hugo https://orcid.org/0000-0003-1259-649X
Gilbert, Alexandra
Velikova, Galina
Ferrer, Montse https://orcid.org/0000-0001-9867-7391
,
Costantini, Massimo
Pe, Madeline
Marzorati, Chiara
Tanzilli, Antonio
Petersen, Morten Aagaard
Machiavelli, Aline
Widder, Joachim
Nina, Helidon
Debruyne, Philip
Petrov, Ivaylo
Ramljak, Vesna
Krini, Maria
Kazda, Tomas
Pappot, Helle
Pääbo, Liina
Valvere, Vahur
Mattson, Johanna
Bredart, Ann
Boulec, Carole
Borinelli-Franzoi, Mariaalice
Kldiashvili, Ekaterina
Brandts, Christian
Erickson, Nicole
Arndt, Volker
Balaoura, Olga
Orsolya, Horvath
Donohoe, Claire
Rizzo, Alessandro
Pace, Andrea
Lejniece, Sandra
Dulskas, Audrius
Pogonet, Vadim
van de Poll, Lonneke
Guren, Marianne Grønlie
Ługowska, Iwona
Litwiniuk, Maria
Bento, Maria José
Ciuleanu, Tudor
Mitrić, Milana
Ratosa, Ivica
Chovanec, Michal
Vieito, Maria
Aguilar, Héctor
Ruiz, Eva
Ahlberg, Karin
Simsek, Eda Tanrikulu
Gumus, Mahmut
Minnée-van Braak, Inke
Higgins, Caitriona
Pinnavaia, Laura
Dantas, Carina
Kalmi, Tapani
Martin, Áurea
Funding for this research was provided by:
HORIZON EUROPE (HORIZON-MISS-2021-CANCER-02 101096362-EUonQoL)
Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR 2021 SGR 00624, FI-1 00266)
Instituto de Investigaciones Farmacéuticas, Universidad de Costa Rica (OAICE-85-2019)
Universitat Pompeu Fabra
Article History
Accepted: 14 December 2024
First Online: 23 January 2025
Declarations
:
: The authors declare no competing interests in this study, except for author GV who declares honoraria from Pfizer, Novartis, Eisai and Lilly; Consultancy fees from AstraZeneca, Roche, Novartis, Pfizer, Seagen, Eisai and Sanofi, and an institutional grant from Pfizer.
: Ethical clearance for this research is not required, as the systematic review only uses information from previously published research.
: Not applicable.
: Not applicable.